Reporter brief
RCT of metformin to prevent muscle loss during bed rest in older adults
What happened
This randomized controlled trial investigated whether metformin could prevent muscle atrophy and insulin resistance in older adults during bed rest. The abstract indicates metformin has shown benefits for insulin sensitivity and muscle preservation in insulin-resistant populations, but this study's specific findings, sample size, and effect sizes are not reported in the available material.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Rct; Human.
Not recorded.
- Design
- Rct
- Sample
- —
- Journal
- University of Utah
- Published
- Dec 5, 2025
Effect size
Not recorded.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Metformin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.